Open company graph database — free web & API
Login

Sysmex Austria Ltd.

Sysmex Austria GmbHSysmex オーストリア GmbHAlias
Ticker
—
Listed market
—
Country
Austria
Employees (non-consolidated)
—
Related companies
14
§01

Basic information

BASIC
Head office
Lienfeldergasse 31-33, 1160 Vienna
Chief executive
Employees (non-consolidated)
Employees (consolidated)
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

0
§04

Related companies

14 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Sysmex Astrego AB Sources
Group
Sysmex R&D Center Europe Ltd. Sources
Group
HITADO GmbH SourcesSources
Group Supplier
Oxford Gene Technology Inc. Sources
Group
Sysmex Partec GmbH Sources
Group
HYPHEN BioMed Sources
Group
Abaxis Sources
Supplier
Eurolyser Sources
Supplier
Fuji Sources
Supplier
Helena Sources
Supplier
Optimedical Sources
Supplier
Japan Kodak Diagnostics Inc. Sources
Supplier
RAL Diagnostics Sources
Supplier
Tosoh Sources
Supplier
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§07

News

64 ARTICLES

HISCL™ for Alzheimer’s blood testsSources

Sysmex is introducing the HISCL™ platform for fast, scalable blood analysis for Alzheimer’s disease. Independent European studies confirmed the high accuracy of HISCL™ p-Tau217 RUO and the HISCL™ Aβ42/40 ratio in the early detection of Aβ pathology. Results are available 17 minutes after a routine blood draw.

Sysmex Among Austria’s Top 1%Sources

Sysmex Austria GmbH was recognized as one of Austria’s top 1% of employers in the LEADING EMPLOYERS 2026 meta-study. The meta-study combines different perspectives rather than relying on individual sources.

Sysmex Austria Receives ISO 27001 CertificationSources

Sysmex Austria has successfully received ISO 27001:2022 certification. The certification reflects the company’s commitment to data protection, security, and trust for employees, customers, and partners.

PA-100 AST Cuts UTI Diagnosis to 45 minSources

The Sysmex PA-100 AST System reduces the time for UTI diagnosis to just 15 minutes and determines optimal antibiotics within 30 minutes, delivering actionable results in 45 minutes. This technology redefines the standard of care for diagnosing and treating uncomplicated urinary tract infections by eliminating delays associated with traditional laboratory testing.

Sysmex launches automated CRC screeningSources

Sysmex Europe SE announced the launch of a fully automated stool analysis solution, expanding its FIT DX™ Series portfolio. The solution is intended to support greater efficiency and scalability in colorectal cancer screening.

OGT Launches SureSeq CLL + CNV V3 PanelSources

OGT announced the launch of its updated SureSeq CLL + CNV V3 NGS panel. The panel uses OGT’s proprietary bait designs to provide broader coverage of disease-associated genes and enhanced CNV detection, enabling more comprehensive variant detection.

PA-100 AST Wins Longitude PrizeSources

Sysmex announced that its subsidiary Sysmex Astrego AB was awarded the Longitude Prize on AMR. The prize recognizes the development of the PA-100 AST System, a rapid antimicrobial susceptibility testing system.

Sysmex opens new branch office in FinlandSources

Sysmex Europe SE announced the establishment of a new branch office, Sysmex Nordic ApS, in Finland to strengthen its market presence in Scandinavia. The move aims to expand sales and support networks in the region. Finland’s modern healthcare system and recent reforms favor innovative medical solutions, emphasizing accurate diagnostics.

Sysmex and CellaVision Expand AllianceSources

Sysmex Corporation and CellaVision AB entered into a strategic alliance to advance hematology solutions and expand their portfolio, including next-generation cell morphology analyzers. The companies will work to improve testing workflow efficiency and standardization, increase the precision of cell morphology classification, and provide value in diagnostic support.

Expanding Direct Sales and Service in ItalySources

Sysmex Corporation will begin providing direct sales and service in Italy for hematology, urinalysis, and hemostasis, in addition to its existing services in life science and industrial flow cytometry. The company aims to grow its market share across test fields and address healthcare providers’ needs through direct communication with customers.

§09

Sources & updates

SOURCES
↑